… ProQR Receives Orphan Drug Designation from FDA for Drug … Present Data at two Scientific Conferences Key Updates ProQR’s drug candidate QR-313 for dystrophic epidermolysis … David M. Rodman, MD, Chief Development Strategy Officer of ProQR, “It highlights the unmet need in this devastating …
… ProQR Announces an Investor and Analyst Event and … LEIDEN, Netherlands, April 25, 2016 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (NASDAQ:PRQR) today announced that … molecule that will move into clinical development using ProQR’s RNA approach. ARVO The p.Cys998X mutation which is a …
… ProQR to Present Interim Phase 1/2 Results for QR-110 in … and will be made available in the “Investors” section of ProQR’s website ( www.proqr.com ) under “Events and Presentations”. About …
… ProQR Announces Positive Interim Results from Phase 1/2 … & CAMBRIDGE, Mass., Sept. 05, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … executive vice president of research and development of ProQR. “We observed a clinically meaningful improvement in …
… ProQR Therapeutics Teams Up with the Foundation Fighting … and CAMBRIDGE, Mass, Feb. 06, 2020 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … for IRDs. Daniel de Boer, Chief Executive Officer of ProQR, said, “We are honored to be the first industry partner …
… ProQR Receives up to $5 Million in Partnership with EB … LEIDEN, the Netherlands, June 12, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … said Daniel A. de Boer, Chief Executive Officer of ProQR. “With the funding from these partners, we plan to …
… ProQR annonce des résultats intermédiaires positifs pour un … Massachusetts, 05 sept. 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), une entreprise qui … vice-président exécutif recherche et développement de ProQR. « Nous avons observé une amélioration cliniquement …
… proprietary Axiomer RNA-editing platform technology. Our ProQRians, representing over 30 nationalities, are passionate … to change the lives of patients and their loved ones. ProQR Therapeutics is a biotech company with offices in …
… Version October 2022 Who we are In this Notice, the words “ProQR”, “We”, “Us” and “Our” refer to ProQR Therapeutics … (DPO) regarding any information, or concerns, related to ProQR’s processing of personal data, by sending an e-mail …
At ProQR we take care to give all applicants a good experience and value their time and interest in applying to become a ProQRian. On this page, you can find an overview of what you can expect throughout the recruitment process, until your first onboarding week.
